While some might consider craft beer the commercialization of innovative biotechnology (we do!), we’re more excited about emerging pharma—the biotechs in pre-clinical and clinical development.
As rare disease and orphan drugs take center stage, we’re only going to see more activity in this market. Which is awesome for creating better therapies, real cures and healthy humans. At the same time, a lot of market noise in an increasingly scientific landscape can pose challenges. While you’re focusing on trials, establishing partnerships, preparing for IPOs, and dealing with the Feds, we’ll focus on getting you noticed and keeping all your constituents educated and informed through strategic and tactical marketing communication.